Cerebral Autoregulation in Patients With Symptomatic Cerebral Atherosclerotic Stenosis

Status: Recruiting
Location: See location...
Intervention Type: Diagnostic test
Study Type: Observational
SUMMARY

In this multi-center prospective observational study within a cohort of symptomatic cerebral atherosclerotic stenosis (sCAS) patients, 850 subjects were planed to be enrolled to explore the relationship between cerebral autoregulation (CA) and stroke recurrence, determine the threshold values of CA parameter for predicting stroke recurrence associated with particular stenosis.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 80
Healthy Volunteers: f
View:

• Age ranging from 18 to 80, both genders

• Unilateral internal carotid artery (ICA) or M1 segment of middle cerebral artery (MCA) stenosis (rate of stenosis ranging from 50-99%)

• Acute ischemic cerebrovascular events (TIA or ischemic stroke) within cerebral stenotic artery supplying area

• Onset of disease \<30 d before enrollment

• Modified Ranking Scale (mRS) ≤1 before stroke onset

• National Institutes of Health Stroke Scale (NIHSS) ≤20

• Sufficient bilateral temporal bone windows for insonation of the middle cerebral artery

• Be conscious, and able to cooperate with CA assessment

• Willing to participate and sign the informed consent

Locations
Other Locations
China
the First Hospital of Jilin University
RECRUITING
Changchun
Contact Information
Primary
Yi Yang, MD, PhD
doctor_yangyi@163.com
0086-13756661217
Backup
Zhenni Guo, MD
zhen1ni2@163.com
Time Frame
Start Date: 2017-01-14
Estimated Completion Date: 2026-08-30
Participants
Target number of participants: 850
Treatments
sCAS patients
Investigators plan to enroll 850 patients of symptomatic cerebral atherosclerotic stenosis (sCAS) for cerebral autoregulation assessment to explore the relationship between cerebral autoregulation (CA) and stroke recurrence, determine the threshold values of CA parameter for predicting stroke recurrence associated with particular stenosis.
Related Therapeutic Areas
Sponsors
Collaborators: Qilu Hospital of Shandong University, The First Affiliated Hospital of Hebei North University, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, The Affiliated Hospital of Yanbian University, The First Affiliated Hospital of University of South China, Shenzhen Second People's Hospital, The Affiliated Hospital of Qingdao University, The First Affiliated Hospital with Nanjing Medical University, Eighth Affiliated Hospital, Sun Yat-sen University
Leads: Yi Yang

This content was sourced from clinicaltrials.gov